Sakata Kenneth K, Klassen Christine L, Bollin Kathryn B, Grys Thomas E, Slack James L, Wesselius Lewis J, Vikram Holenarasipur R
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12684. Epub 2017 Apr 12.
Stem cell transplant (SCT) recipients commonly undergo bronchoalveolar lavage (BAL) collection as an infectious pulmonary work-up. Previous studies report the utility and overall diagnostic yield of fiberoptic bronchoscopy with BAL in this vulnerable population, though none focused purely on microbiologic yield or made comparisons with less invasive means of pathogen detection. We sought to determine and elaborate on the microbiologic yield of BAL in SCT recipients, assess a correlation between BAL studies and less invasive means of pathogen detection, and assess the utility of repeating a BAL within 30 days.
Between January 1, 2009, and July 31, 2013, we reviewed medical records of 125 SCT recipients who underwent 179 BALs. In addition to demographic information and details pertaining to their SCT, a comprehensive review of their microbiologic data was performed and recorded.
Our study showed an overall BAL microbiologic yield of 40%, despite 92% of patients receiving broad-spectrum antimicrobial therapy at the time of the BAL procedure.
Although an initial BAL sample in this population provides crucial microbiologic information, repeating the procedure within 30 days may have minimal additional microbiologic yield. BAL continues to be an essential diagnostic tool in SCT recipients undergoing an infectious pulmonary work-up.
干细胞移植(SCT)受者通常会接受支气管肺泡灌洗(BAL)采集,作为肺部感染检查的一部分。既往研究报告了在这一脆弱人群中纤维支气管镜检查联合BAL的效用和总体诊断率,不过没有一项研究单纯聚焦于微生物学检出率,也没有与侵入性较小的病原体检测方法进行比较。我们试图确定并详细阐述SCT受者BAL的微生物学检出率,评估BAL检查与侵入性较小的病原体检测方法之间的相关性,并评估在30天内重复进行BAL的效用。
在2009年1月1日至2013年7月31日期间,我们回顾了125例接受179次BAL的SCT受者的病历。除了人口统计学信息和与他们的SCT相关的详细信息外,还对他们的微生物学数据进行了全面回顾并记录。
我们的研究显示,尽管92%的患者在进行BAL操作时接受了广谱抗菌治疗,但BAL的总体微生物学检出率为40%。
虽然该人群的初始BAL样本可提供关键的微生物学信息,但在30天内重复该操作可能只会带来极少的额外微生物学检出率。对于正在接受肺部感染检查的SCT受者,BAL仍然是一种重要的诊断工具。